← Back to Company DatabaseVisit Website
Recursion Pharmaceuticals
AI-driven drug discovery platform for oncology and rare diseases.
PublicSalt Lake City, UTFounded 2013
About
Recursion Pharmaceuticals uses AI and automation to discover new drugs across multiple therapeutic areas including oncology. The company generates massive biological datasets through high-throughput experiments and uses machine learning to identify novel drug candidates. Its platform integrates biology, chemistry, and AI at industrial scale.
Total Funding
$800MKey Product
Recursion OS AI drug discovery platformGeography
North AmericaKey Investors
Baillie GiffordSoftBank Vision FundCasdin Capital
Focus Areas
Drug DiscoveryAI / Machine LearningTreatment (Therapeutics)
Technology
AI / Machine LearningDigital Health / Software
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026